Acute megakaryoblastic leukemia FAB M7
Robak, T.
Acta Haematologica Polonica 18(3-4): 179-186
1987
ISSN/ISBN: 0001-5814 PMID: 3330394 Document Number: 301365
Document emailed within 1 workday
Related Documents
Tange, T.; Nakahara, K.; Mitani, K.; Yamasaki, I.; Yasuda, H.; Tanaka, F.; Mizuguchi, M.; Oda, H.; Yatomi, Y.; Takanashi, R. 1988: Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis Cancer Research 48(21): 6137-6144Soler, J.; Brunet, S.; Bordes, R.; Rubiol, E.; Mitjavila, M.; Pujol-Moix, N. 1987: Acute megakaryoblastic leukemia (M7). Immunocytochemical and ultrastructural study of 2 cases Medicina Clinica 88(2): 68-70
Kiss, A.; Oláh, E.; Iványi, J.L.; Pecze, K.; Telek, B.; Pfliegler, G.; Rák, K. 1986: The megakaryoblastic phase of chronic granulocytic leukemia Orvosi Hetilap 127(15): 871-877
Itano, M.; Tsuchiya, S.; Minegishi, N.; Fujie, H.; Minegishi, M.; Morita, S.; Yambe, T.; Ohashi, Y.; Masuda, T.; Koike, T. 1995: Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability Experimental Hematology 23(12): 1301-1309
Nagata, K.; Okano, Y.; Nozawa, Y. 1997: Differential expression of low Mr GTP-binding proteins in human megakaryoblastic leukemia cell line, MEG-01, and their possible involvement in the differentiation process Thrombosis and Haemostasis 77(2): 368-375
Bidwai-Bhattacharjee, M.; Shome, D.K.; Srinivas, M.; Ghosh, K.; Verma, S.; Mohanty, D.; Bhagwat, A.G.; Das, K.C. 1986: Acute megakaryoblastic leukaemia--an underdiagnosed entity Indian Journal of Cancer 23(2): 75-82
Reeves, B.R.; Knight, J.C.; Renwick, P.J.; Jani, K.; Kempski, H. 1995: A case of acute megakaryoblastic leukaemia with t(X;6)(p11.21;q23) having an X chromosome breakpoint within a 450-Kb region which is also disrupted in two classes of solid tumours Leukemia 9(4): 723-725
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449
Cantore, N.; Fotino, A.; Volpe, S.; Santaniello, L.; Pagnini, D.; Volpe, E. 1985: A case of transformation of an untreated acute lymphocytic leukemia into acute erythroblastic leukemia (di Guglielmo's disease) Haematologica 70(4): 375-376
Promsuwicha, O.; Auewarakul, C.U. 2009: Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations Asian Pacific Journal of Allergy and Immunology 27(4): 209-216
Degos, L. 1973: Leukemias. Fundamental data. Epidemiology of acute human leukemia. the risk of acute leukemia La Revue du Praticien 23(1): 91-94
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356
Kanakura, Y.; Sugahara, H.; Mitsui, H.; Ikeda, H.; Furitsu, T.; Yagura, H.; Kitayama, H.; Kanayama, Y.; Matsuzawa, Y. 1993: Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor Cancer Research 53(3): 675-680
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352